November 2020
Breakthrough treatment trial for peanut allergy
A new oral treatment can reduce sensitivity to peanuts
|
|
Scientists use blood test to predict who is likely to develop psychotic disorders.
|
|
|
Improving treatment for Von Willebrand Disease |
|
|
New Therapies for patients with drug-resistant epilepsy
Researcher have identified a critical new step in how brain cells function in people with one of the most common forms of epilepsy.
|
|
RCSI Discover blog
A blog from scientists at RCSI University of Medicine and Health Sciences aims to provide quick-to-read scientific summaries of the most up to date RCSI research.
|
RCSI University of Medicine and Health Sciences is ranked number one globally for Good Health and Well-being in the Times Higher Education (THE) University Impact Rankings 2020. RCSI is among the top 250 of universities worldwide in the THE World University Rankings (2020) and its research is ranked first in Ireland for citations. It is an international not-for-profit university, with its headquarters in Dublin, focused on education and research to drive improvements in human health worldwide. RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education. From time to time, RCSI will share research and education news of legitimate interest to you as a valued peer and colleague. You are included in this audience based on one of the following: opt-in, recent RCSI education/research event participation, nomination by an education/research collaborator or peer at RCSI. If you wish to stop receiving this news, please click "Manage Subscription" below. RCSI's Privacy Policy is available here. |
RCSI University of Medicine & Health Sciences